National Cancer Diagnosis Audit

Slides:



Advertisements
Similar presentations
For primary and secondary care settings
Advertisements

National Prostate Cancer Audit Heather Payne, NPCA Oncological Clinical Lead Consultant Clinical Oncologist, UCL.
A Health Needs Assessment for Adults with a Learning Disability in Nottingham and Nottinghamshire Presented at the Help and Advice for Learning Disability.
Nicola Barnstaple Programme Manager. Key challenges in Scotland Increasing cancer incidence – predicted 35,000 cases per year in 2020 Ageing population.
Early Diagnosis of Cancer Working with GP Practices in Islington.
Background The 2 week wait referral system was designed to expedite the referral of patients, suspected to have cancer, from Primary to Secondary care.
Henrik Møller, Carolynn Gildea, David Meechan, Greg Rubin, Thomas Round, Peter Vedsted Cancer Epidemiology and Population Health, KCL (HM) Public Health.
Cancer care commissioning priorities – South East London Summary of discussions from meeting held: Tuesday 10 th July, 6pm-8pm at Guy’s Hospital.
Increasing awareness and early diagnosis of cancer An update from Primary Care Jo Preston Service Improvement Facilitator NECN Dr Bill Hall Primary Care.
Chester Ellesmere Port & Neston Rural Making sure you get the healthcare you need West Cheshire CCG Strategy Dr Andy McAlavey Medical Director West Cheshire.
Significant Events. Significant Event Analysis (SEA) An SEA is concerned with investigating any occurrence which are identified by any practice members.
National Cancer Intelligence Network data usage 17 November 2015 – Veronique Poirier – Principal Cancer Analyst – NCIN.
Improving Cancer Outcomes in Camden Dr Lucia Grun 19 March 2014.
National Cancer Survivorship Initiative 2010 Update.
East Midlands Strategic Clinical Networks & Senate Cancer Roadshow.
[NAME CCG] [DATE] [FACILITATOR] Early Diagnosis of Cancer Quality Improvement using Cancer Significant Event Analysis [CCG MAP]
The Royal College of Emergency Medicine Assessing for Cognitive Impairment in Older People Clinical Audit National findings The Royal College of.
Cheshire and Merseyside Strategic Clinical Networks Local Issues and Challenges 22 nd May 2015.
Prostate cancer and socio-economic deprivation When PCTs are ranked according to their income score using the Indices of Multiple Deprivation (IMD)* there.
Cancer Research UK Facilitator Programme: Working in partnership to improve cancer outcomes Marion O’Neill March 2017.
28 Day Faster Diagnosis Standard
Macmillan Ipswich Diagnostic Assessment Service (MIDAS)
FIT Programme (Faecal Immunohistochemical Test)
Implementation of a lung health clinic in high-risk individuals in South East London: a prospective feasibility cohort study Background In 2013, lung cancer.
National Clinical Pathway for suspected and confirmed lung cancer:
Refer to Beds & Herts Breast Cancer Family History Screening service
Andrew Low Respiratory Consultant BRI SWAG Lung SSG 15 November 2016
Accessing health information in the UK
Cancer Audit Stourport Health Centre Feb 2016
Indicators and Outcomes Framework – relevance to patients and commissioners Parul Desai NHS England, London : 7 June 2016.
Oesophago–Gastric Cancer
For Healthy Women who are at low risk of complications in pregnancy and childbirth. The Free Standing Midwifery Unit at Ysbyty Glan Clwyd Is it a safe.
Hypertension November 2016
[NAME CCG] [DATE] [FACILITATOR]
The use of community group peer education models to reduce knowledge barriers in symptom awareness for over 50s and the Bangladeshi population in Camden.
National Oesophago–Gastric Cancer Audit 2015.
Prepared by staff in Prevention and Cancer Control.
Jane E Scullion Respiratory Nurse Consultant
Segmented analysis of prostate cancer pathway from referral to treatment: This work was carried out in partnership between the Transforming.
Dr James Carlton, Medical Adviser
Welcome to Wessex Strategic Clinical Networks Transformation Project Workshop 20/09/2018.
Unscheduled Care Analysis
National Cancer Diagnosis Audit in England Greg Rubin Professor of General Practice and Primary Care Newcastle University, UK.
INTRODUCTION TO COMMUNITY PHARMACY
Challenges Vision ‘How’ Objectives Outcome Aspirations
LUNG CANCER SEA L+SC CANCER ALLIANCE
BOWEL CANCER SCREENING 11/7/18
Primary care engagement Programme
National Cancer Diagnosis Audit
Local Tobacco Control Profiles The webinar will start at 1pm
Strength of Evidence; Empirically Supported Treatments
[NAME CCG/Health Body] [DATE] [FACILITATOR]
Refer to Beds & Herts Breast Cancer Family History Screening service
Segmented analysis of the lung cancer median pathway from referral to treatment: This work was carried out in partnership between the Transforming.
Information for Patients Please return to reception
Barts Health Trust 2WW Colorectal Workshop Dr Angela Wong,
Routes to diagnosis reimagined
Breast cancer pathway update – Primary care pathways event
National Oesophago-Gastric Cancer Audit 2018 Annual Report: Slide set
Somerset, Wiltshire, Avon & Gloucestershire Cancer Alliance
Two Week Wait Referral Forms
Assessing for Cognitive Impairment
Hypertension November 2016
FIT for symptomatic patients
Consultant Clinical Biochemist
Living With & Beyond Cancer (Personalised Care): SWAG Colorectal CAG Update 5th June 2019 Catherine Neck, Macmillan Cancer Rehabilitation/ LWBC Lead On.
NHS Long Term Plan: Rapid Diagnostic Centres (RDC) The SWAG Approach
Colorectal 2 week wait pathways and “Getting FIT”
Principal recommendations
Presentation transcript:

National Cancer Diagnosis Audit Yorkshire and Humber Regional Feedback. ( With some local data added in!) 2014 Cancer Diagnoses. Audit 2017. Did not get enough practices taking part to get a CCG level report.

Audit Summary The NCDA gathered primary and secondary care data from patients diagnosed with cancer in 2014 across England to understand pathways to cancer diagnosis 439 practices took part in the England audit (this is 5.4% of all practices in England) 17,043 patient records were collected (this is 5.7% of all patients diagnosed with cancer in 2014) The audit is also taking place in Scotland and North Wales 6 practices locally took part covering 38% of SRCCG population. 2 practices have shared their reports. SMG – 110 patients. Eastfield – 45 patients. Remember that with all this data – the numbers involved are small so the confidence intervals will be huge – think of them as a guide only!

AUDIT Objectives The audit seeks to gather data about Interval length from patient presentation to diagnosis Use of investigations prior to referral What the referral pathways for patients with cancer are and how they compare with those recorded by the cancer registry In future, the 2014 audit data will Help to understand the patterns of cancer diagnosis for all cancer types across the UK, prior to the 2015 NICE guidance on cancer referrals (NG12) Help with assessing the impact of the new guidelines

Benefits for Practices Enabling more efficient and effective pathways to diagnosis Improving patient experience and outcomes Highlighting good practice Highlighting diagnostic challenges Identifying patients for SEAs Opportunity for case study discussion and peer review Demonstrating quality improvement for GP appraisal, revalidation and CQC inspection Opportunity to influence local commissioning decisions

Demographics of Cancer patients in 2014 AUDIT National Y&H Gender Male Female 50.1% 49.9% 51.2% 48.8% Age (Age group with the biggest proportion) 65-74 years (28.6%) Median – 69 years 29.4% Median – 70 years Ethnicity White Non-white Not known 81.3% 4.3% 14.5% 90.7% No information on deprivation taken which would have been interesting. SMG data Male 53.6% Median age 73 White 81.3%. Eastfield data Female 51.1% Median age 75 White 100%.

Cancer Types Diagnosed in 2014 AUDIT Y & H National SMG East. Breast 239 14.5% 2714 15.9% 19.1% 11.1% Prostate 230 13.9% 2130 12.5% 16.4% 8.9% Lung 232 14% 2132 10% 17.8% Bowel 201 12.2% 1969 11.6% 12.7% 20% Other cancer types 46 41.8% 8098 47.5% SMG have a higher breast cancer rate – but the screening may have just been done. Eastfield appear to have a higher bowel cancer rate ( but this only represents 9 patients so ? Significance). Bowel screening rate in 2014 dipped at Eastfield to 54%. ? If relevant??

Cancer Stage 42.9% of cancers in 2014 were diagnosed at an early stage (stage 0, 1 or 2) in Y+H compared to 41.9% in practices taking part in the NCDA nationally. Insert the figure from your report “Cancer Stage – All cancers” here Data for the whole of England for cancer diagnoses in 2014 show*: 25% were stage 1 16% were stage 2 14% were stage 3 20% were stage 4 *Cancer Research UK – Cancer Statistics Some variation though across practices – remembering that the numbers are small so ? Significance. SMG Eastfield Early stage 42.7% 33.3% Late stage 40.9% 44.4%

Place of presentation The most common place where patients first presented with symptoms later attributed to the cancer was the GP surgery – 70.8% in Y&H, 67.5% England,77.3% SMG, 73.3% Eastfield. Insert the figure from your report “Place of Presentation – All cancers” here Higher numbers than the England average present to us in primary care first. Opportunity here….

Primary Care Interval The primary care interval is the time from first presentation (with a symptom later attributed to cancer) to referral. The median primary care interval for Y&H was 5 days. The median primary care interval for Eastfield was 0 days The median primary care interval for SMG was 7 d ays. Nationally this was 4 days. Add information about the length of the primary care interval to this slide. You can find this information in the Primary Care Interval summary paragraph and in the Primary Care Interval section in your report. Number 1 – length of median primary care interval for your practice (in days) Number 2 – length of median primary care interval for cluster (in days) You may wish to discuss how your practice compares nationally / to the cluster median value. The primary care interval should be as short as possible, but there may be good reasons for some longer intervals, such as waiting for test results of investigations ordered in primary care. Is there anything you could do to shorten your intervals further? How long do test results usually take to come back? What processes are in place to chase up test results? What safety-netting approaches are being used to ensure patients are followed up? Remember to emphasise that the national figures are only for practices that took part in the NCDA. This may therefore not reflect the actual national picture in 2014.

Primary Care Consultations The median number of primary care consultations before the referral that led to a cancer diagnosis was 1 in Y&H – same as for England. The proportion of patients who had less than 3 consultations prior to referral was ; England Y&H SMG Eastfield 66.2% 65.3% 48.2% 55.6% Significant variation though with SMG and Eastfield averaging 2 consultations before referral. The range though is huge – Y+H 0-39 consultations - SMG 0-39 consultations. - Eastfield 0-22 consultations. Suggesting that patients are being seen several times before a referral is made. Generally, the number of consultations before referral should be low, but there may be good reasons for higher numbers of consultations as practices are encouraged to use more primary care investigations. Therefore, investigations being done and test results being discussed might explain higher numbers of consultations. Is there anything you could do to reduce the number of consultations? What investigations are being ordered (see next slide) and are they appropriate? What processes are in place to chase up test results? Remember to emphasise that the national figures are only for practices that took part in the NCDA. This may therefore not reflect the actual national picture in 2014.

Investigations in primary care There are a number of investigations (such as blood tests, PSA and chest x-rays) that may be ordered in primary care to explore potential symptoms of cancer before referral National Y&H SMG East. Proportion with no investigati on 34.5% 33.9% 37.1% 45.6% Most referrals are made on the basis of symptoms and signs though – nil investigation needed prior to referral. The most common investigation was blood tests across England, locally and the practices.

Referral Types From Primary Care “Type of referral” is what the GP considered to be the type of referral that led most directly to a diagnosis of cancer The most common type of referral that led to a diagnosis of cancer was 2WW England 51.% Y+H 54.9% SMG 47.3% Eastfield 51.1% Add information about referrals to this slide. You can find this information in the Referrals section in your report. Most common referral type – type of referral done for the biggest proportion of patients that led to cancer diagnosis Per cent 1 – percentage of patients that were referred through this route You may copy and paste the bar graph showing the types of referrals from your report onto this slide to stimulate discussions about the types of referrals being used. You can use the additional information about emergency referral routes in the report to discuss in more detail how patients at your practice were referred as emergencies and whether there is anything that could have been done differently. There were different types of emergency referral routes captured in the audit and an emergency referral may not be an inappropriate route, therefore it will be important to discuss the types of emergency referral route. Consider referring to recent publication Zhou et al. Diagnosis of cancer as an emergency: a critical review of current evidence. 2017 Jan;14(1):45-56. Note: The “Type of referral” is what the GP considered to be the type of referral that led most directly to a diagnosis of cancer. The “Route to diagnosis” is based an algorithm that NCRAS has developed which looks through many datasets to determine what the final route to diagnosis was. The GP then had the opportunity to confirm whether they believed this to be true or enter the route they thought.  For the majority of patients, the patients were referred by TWW and were diagnosed by this route, but there are cases where this could be different. For example, if a patient was referred by TWW but actually ended up being diagnosed in A&E. Also the route to diagnosis shows when the patient was diagnosed at death and no referral would have taken place. The use of the two variables together shows the intention of the referral but also what actually happened.

Route to diagnosis “Route to diagnosis” is based on an algorithm which looks through many datasets to determine what the final route to diagnosis was The most common route to diagnosis was 2WW. England – 38% Y&H - 46.2% SMG - 36.4% Eastfield - 44.4% Insert the figure from your report “Route to Diagnosis – All cancers” here Note: The “Type of referral” is what the GP considered to be the type of referral that led most directly to a diagnosis of cancer. The “Route to diagnosis” is based an algorithm that NCRAS has developed which looks through many datasets to determine what the final route to diagnosis was. The GP then had the opportunity to confirm whether they believed this to be true or enter the route they thought.  For the majority of patients, the patients were referred by TWW and were diagnosed by this route, but there are cases where this could be different. For example, if a patient was referred by TWW but actually ended up being diagnosed in A&E. Also the route to diagnosis shows when the patient was diagnosed at death and no referral would have taken place. The use of the two variables together shows the intention of the referral but also what actually happened.

Avoidable delays The audit asked GPs to provide details if they felt a patient had experienced an avoidable delay. Insert the figure from your report “Avoidable Delays – All cancers” here The proportion of patients with no avoidable delay in Y&H was 65.7% compared to 64.4% for practices taking part in the NCDA nationally. The most common type of avoidable delay reported in our area was primary care. Although 50% patients with avoidable delays at Eastfield were thought to be secondary care.

Take home messages. Think “could this be cancer?” Use the two week wait system for referral. Refer quickly. Don’t let investigations or clinical doubt slow you done. Undertake Significant Event Analysis on emergency diagnoses of cancer to see if there is any learning. Think about doing the next NCDA when asked!